Chunlin Yang (杨春林), PhD
Chunlin Yang serves as Vice President of Technology Development. With over 20 years of experience in biomaterials, biopolymers, and tissue engineering, Dr. Yang has held senior roles at FibroGen (FGEN) where he led the development of a biosynthetic cornea using recombinant human collagen. At Johnson & Johnson, he developed a novel biosynthetic composite technology for reconstructive surgery and soft tissue replacement and served as a Research Fellow in the Advanced Technologies and Regenerative Medicine (ATRM) unit and the Center for Biomaterials and Advanced Technologies (CBAT).
His scientific accomplishments have been recognized within the industry and awarded the J&J Excellence in Science Award and has authored over 40 patent applications and more than 30 scientific papers in the fields of collagen-based biomaterials, medical devices, controlled drug delivery, and tissue engineering. Dr. Yang received his PhD in Biochemistry through the joint program of the Chinese Academy of Sciences in Beijing and Medical University of Luebeck, Germany and completed his post-doctoral fellowships at Medical University of Luebeck, the National Institutes of Health, and Thomas Jefferson University; he received a MS in Environmental Chemistry at the Chinese Academy of Sciences, and BS in chemistry at the University of Inner Mongolia.